
Jasper Therapeutics, Inc.
Jasper Therapeutics, Inc.(JSPR)股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
jspr · 股价预测 · 13 位分析师(近3月)· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 13 位华尔街分析师
Buy
13 位分析师
共识
评级分布
12 个月目标价
High
$3.00
Consensus
$3.00
+541.0% upside
Low
$3.00
Median: $3 · Last Close: $0.47
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
Low Activity算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $0.44 | ↓ 5.00% |
1-day model range: $0.43–$0.46. Peak: $0.46 (-5.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · JSPR · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-15 | TD Cowen | Downgrade ↓ | Buy→Hold |
| 2026-05-15 | RBC Capital | Maintains | Sector Perform→Sector Perform |
| 2026-04-01 | Evercore ISI Group | Maintains | Outperform→Outperform |
| 2025-11-11 | RBC Capital | Maintains | Sector Perform→Sector Perform |
| 2025-09-22 | Evercore ISI Group | Maintains | Outperform→Outperform |
| 2025-09-22 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2025-09-22 | BTIG | Maintains | Buy→Buy |
| 2025-08-15 | UBS | Maintains | Buy→Buy |
| 2025-07-08 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2025-07-08 | Evercore ISI Group | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Jasper Therapeutics, Inc. (JSPR) stock. Of the recent 57 rating actions, 0 were upgrades and 4 were downgrades. 13 analysts currently cover JSPR.
分析师推荐趋势
JSPR analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 4 to 0 per month.
财务预测:EPS 与营收一致预期
Revenue This Year
$1M
↓ 96.7% YoY
Revenue Next Year
$0M
↓ 84.4% YoY
EPS This Year
$-1.03
EPS Next Year
$-1.22
↑ 18.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast JSPR EPS of $-1.03 for the current fiscal year, based on estimates from 4 analysts. The JSPR revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
JSPR 股价预测由两类独立数据源支撑:来自 13 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。JSPR 的共识目标价为 $3.00(+541.0% 上行空间),分析师共识为 Buy。
JSPR 的短期预测(明日)为 $0.44(-5.00%)。
Jasper Therapeutics, Inc. 在 NASDAQ 上市,代码 JSPR。JSPR 在 2027 年的整体展望偏积极,在覆盖分析师中约 62% 对应 Buy 共识。
常见问题
JSPR 预测 · 8 个问题根据 13 位华尔街分析师,JSPR 的 12 个月平均目标价为 $3.00,最高 $3.00、最低 $3.00。若有图表,中位目标价可在上方查看。相对当前价 $0.47,隐含约 +541.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.